K

Telesis Bio logo

Telesis Bio

Healthcare & Life Sciences

Recent Finacing

Equity

Recent Raise

$21M


Telesis Bio develops and promotes the Gibson SOLA technology, a next-generation enzymatic synthesis platform.

Total Funding

$21M

Headquarters

N/A

Founded

N/A

Website

Focus Areas

Enzymatic synthesis
biotechnology
platform
technology adoption
cash-flow breakeven.

Investors

Novalis LifeSciences logo
Northpond Ventures logo